Physician

Kevin Tyler Nash, MD, PHD

According to 2025 Medicare claims, Kevin Nash, MD, PHD (NPI: 1326201856) practices dermatology in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is NASH DERMATOLOGY, LLC (NPI: 1942742325; TIN: 811793240) and primary practice location at 36830-6480.

Nash's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,056 traditional Medicare patients, billed 5,505 HCPCS/CPT codes, and received $494,167 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 2,203 prescription claims across 694 beneficiaries totaling $2,516,474 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 142 records totaling $36,667. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $507,003 and ending at $494,167. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $348,670 to $2,516,474. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,435	10,715	$507,003
2016	1,664	10,380	$610,301
2017	1,098	7,095	$355,449
2018	1,371	8,687	$544,090
2019	1,404	8,557	$614,069
2020	1,223	7,978	$639,538
2021	1,174	7,363	$701,957
2022	970	5,741	$524,967
2023	1,026	5,854	$644,693
2024	1,056	5,505	$494,167

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	536	1,637	$348,670
2016	606	1,947	$572,261
2017	558	1,631	$602,054
2018	686	2,225	$1,053,988
2019	769	2,278	$1,420,570
2020	654	2,063	$1,391,757
2021	665	2,017	$1,342,243
2022	544	1,670	$1,577,722
2023	564	1,612	$1,410,887
2024	694	2,203	$2,516,474

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	259	354	$398
11102	Biopsy of related skin growth, first growth	300	352	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	616	810	$52
17000	Destruction of precancer skin growth, 1 growth	391	473	$31
17003	Destruction of precancer skin growth, 2-14 growths	312	1,848	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	72	2,016	$854,057
Skyrizi Pen	Risankizumab-Rzaa	21	1,596	$456,266
Tremfya	Guselkumab	25	1,316	$336,870
Otezla	Apremilast	45	1,350	$216,727
Dupixent Syringe	Dupilumab	46	1,288	$170,577

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$36,667	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin Tyler Nash, MD, PHD?

Tedicare shows public-source Medicare data for Kevin Tyler Nash, MD, PHD (NPI 1326201856), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Tyler Nash, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin Tyler Nash, MD, PHD?

Kevin Tyler Nash, MD, PHD is linked to NASH DERMATOLOGY, LLC (billing NPI 1942742325) in the available physician profile data.

Does Kevin Tyler Nash, MD, PHD have Open Payments data?

Kevin Tyler Nash, MD, PHD has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.